Spago Nanomedical AB (publ) (STO:SPAGO)
0.1100
0.00 (0.00%)
Jun 11, 2026, 5:14 PM CET
Spago Nanomedical AB Employees
Spago Nanomedical AB had 7 employees as of December 31, 2025. The number of employees decreased by 6 or -46.15% compared to the previous year.
Employees
7
Change
-6
Growth
-46.15%
Revenue / Employee
876.80K SEK
Profits / Employee
-5.18M SEK
Market Cap
72.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | -6 | -46.15% |
| Sep 30, 2025 | 8 | -4 | -33.33% |
| Jun 30, 2025 | 8 | -4 | -33.33% |
| Mar 31, 2025 | 9 | -3 | -25.00% |
| Dec 31, 2024 | 13 | 0 | - |
| Sep 30, 2024 | 12 | -1 | -7.69% |
| Jun 30, 2024 | 12 | -1 | -7.69% |
| Mar 31, 2024 | 12 | -2 | -14.29% |
| Dec 31, 2023 | 13 | -1 | -7.14% |
| Sep 30, 2023 | 13 | -2 | -13.33% |
| Jun 30, 2023 | 13 | -2 | -13.33% |
| Mar 31, 2023 | 14 | -1 | -6.67% |
| Dec 31, 2022 | 14 | -4 | -22.22% |
| Sep 30, 2022 | 15 | -2 | -11.76% |
| Jun 30, 2022 | 15 | -2 | -11.76% |
| Mar 31, 2022 | 15 | -1 | -6.25% |
| Dec 31, 2021 | 18 | 0 | - |
| Sep 30, 2021 | 17 | 2 | 13.33% |
| Jun 30, 2021 | 17 | 1 | 6.25% |
| Mar 31, 2021 | 16 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| IRLAB Therapeutics AB | 31 |
| Biovica International AB | 24 |
| AcouSort AB | 11 |
| Fluicell AB | 11 |
| Alzinova AB | 7 |
| Annexin Pharmaceuticals AB | 4 |
| Modus Therapeutics Holding AB | 2 |
Spago Nanomedical AB News
- 5 weeks ago - Spago Nanomedical AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Spago Nanomedical AB Quarterly report: Q4 2025 - Filings
- 4 months ago - Spago Nanomedical AB Annual report: Q4 2025 - Filings
- 7 months ago - Spago Nanomedical AB Transcript: Life Science Summit 2025 - Transcripts
- 8 months ago - Spago Nanomedical AB Quarterly report: Q3 2025 - Filings
- 10 months ago - Spago Nanomedical AB Quarterly report: Q2 2025 - Filings